AN ONGOING EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCERCROSSOVER TRIAL COMPARING SINGLE-AGENT PACLITAXEL AND DOXORUBICIN AS FIRST-LINE AND SECOND-LINE TREATMENT OF ADVANCED BREAST-CANCER
Mj. Piccartgebhart et al., AN ONGOING EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCERCROSSOVER TRIAL COMPARING SINGLE-AGENT PACLITAXEL AND DOXORUBICIN AS FIRST-LINE AND SECOND-LINE TREATMENT OF ADVANCED BREAST-CANCER, Seminars in oncology, 23(5), 1996, pp. 11-15